APA引文

Martínez, E., d'Albuquerque, P. M., Pérez, I., Pich, J., & Gatell, J. M. (2013). Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir. Mary Ann Liebert, Inc.

Citação norma Chicago

Martínez, Esteban, Polyana M. d'Albuquerque, Ignacio Pérez, Judit Pich, and José M. Gatell. Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir. Mary Ann Liebert, Inc, 2013.

MLA引文

Martínez, Esteban, et al. Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir. Mary Ann Liebert, Inc, 2013.